G2TT
来源类型Discussion paper
规范类型论文
来源IDDP11487
DP11487 The Effects of Pharmaceutical Innovation on Cancer Mortality
Margaret Kyle; Pierre Dubois
发表日期2016-09-02
出版年2016
语种英语
摘要Cancer is a leading cause of death in developed countries, and cancer treatments are the top category of pharmaceutical spending in the United States and Europe. This paper assesses whether novel cancer therapies are associated with a reduction in mortality. Using panel data from 11 developed countries, we study the relationship between mortality attributed to a specific cancer site and the availability of pharmaceutical treatments. The cross-country and cross-site variation over time allows us to isolate the decline in mortality attributable to new drugs from that due to changes in lifestyle and environmental factors. We correct for the endogeneity of mortality and the availability of new treatments using instrumental variables. On average, our results show a decline in mortality of 8-9% is associated with the availability of one new treatment for a cancer site. The gains vary across countries and cancer sites. Based on spending from 2000-2011, costs per statistical life saved ranged from $11-12K for bladder and liver cancers to over $150K for cervical, melanoma and stomach cancers. Across countries, Switzerland had the largest spending per statistical life at approximately $66K, while the UK had the lowest with $19K.
主题Industrial Organization
关键词Pharmaceuticals Cancer Innovation Health
URLhttps://cepr.org/publications/dp11487
来源智库Centre for Economic Policy Research (United Kingdom)
资源类型智库出版物
条目标识符http://119.78.100.153/handle/2XGU8XDN/540301
推荐引用方式
GB/T 7714
Margaret Kyle,Pierre Dubois. DP11487 The Effects of Pharmaceutical Innovation on Cancer Mortality. 2016.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Margaret Kyle]的文章
[Pierre Dubois]的文章
百度学术
百度学术中相似的文章
[Margaret Kyle]的文章
[Pierre Dubois]的文章
必应学术
必应学术中相似的文章
[Margaret Kyle]的文章
[Pierre Dubois]的文章
相关权益政策
暂无数据
收藏/分享

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。